Cervical Cancer Diagnostic Tests Market - Global Industry Analysis Report, 2014 - 2020

Cervical cancer is the third most common cancer among women and has become the second most common cause of cancer-related deaths across the globe. The deadly disease accounts for around 300,000 deaths annually. Appropriate screening methods and diagnostic tests help in early detection of cervical cancer. The global cervical cancer diagnostic tests market is estimated to expand at a CAGR of 6.10% during the period between 2014 and 2020. The overall market was worth US$5.9 bn in 2013 and is expected to reach a valuation of US$8.9 bn by 2020.

Browse Full Report: http://www.transparencymarketresearch.com/cervical-cancer-diagnostic-tests-market.html

Diagnostic Tests in High-Income Nations Curbing Occurrence of Cervical Cancer

One of the most common risk factors for cervical cancer is infection by the human papilloma virus (HPV). Other risk factors include smoking, Chlamydia infection, long-term use of oral contraceptives, family history of cervical cancer, and others. HPV testing, Pap smear tests, endocervical curettage (ECC), cone biopsy, loop electrosurgical excision procedure (LEEP), and colposcopy are some of the commonly used diagnostic tests for cervical cancer. In 2013, Pap smear tests accounted for more than 45% of the global cervical cancer diagnostic tests market owing to the high efficacy of the tests at relatively low costs. However, the low cost of Pap smear tests has not helped to decrease the number of patients affected with cervical cancer across lower income countries.

According to a new study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research, the prevalence of infection-related cancers such as stomach, liver, and cervical cancers as well as lung, breast, and colorectal cancers has increased in low- and middle-income countries. The increasing prevalence of cervical cancer is a major concern across Southeast Asia, Sub-Saharan Africa, Central and Eastern Europe, and Latin America and the Caribbean. In high-income nations, screening programs implemented years ago have helped to curb cervical cancer rates by as much as 4% annually.

Cervical Cancer Prevention Program in Haiti: A Concrete Step to Fight the Disease

In Haiti, around 3,000 women get cervical cancer each year and almost half of them die from the illness. In fact, the country registers the highest rate of cervical cancer across the world. Partners in Health, a Boston-based non-profit organization, has launched a two-year pilot program in Haiti to screen 20,000 women for cervical cancer and vaccinate around 6,000 girls against the strains of human papilloma virus. Zanmi Lasante, the Haitian program of Partners in Health, plans to reach around to 60,000 people, making them aware about the disease.

Request For Custom Research: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=736

In the near future, the global cervical cancer diagnostic tests market is expected to gain impetus from the demand arising from low- and middle-income countries. Though these countries lack resources to fight against the disease, development of cervical cancer prevention strategy along with donation of vaccines and other supplies will help to decrease the prevalence of the disease. For example, in Haiti, the U.S. Agency for International Development is supporting the pilot program launched by Zanmi Lasante. To avail vaccines and other supplies for the patients, the non-profit organization is coordinating with drug manufacturing company Merck & Co.

Optical Imaging Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

A research study on the global optical imaging market, published by Transparency Market Research (TMR), estimates the market to expand at a healthy CAGR of 10.80% during the period from 2014 to 2020 and reach a market value of US$2.1 bn by the end of the forecast period.The research report, titled “Optical Imaging Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020”, states that the global optical imaging market stood at US$1 bn in 2013.

Browse the full Optical Imaging Market (Technologies: Optical Coherence Tomography, Hyperspectral Imaging, Near Infrared Spectroscopy, Photoacoustic Tomography; Applications: Ophthalmology, Dentistry, Dermatology, Cardiology, Neurology, Oncology & Biotechnology & Research) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 report at http://www.transparencymarketresearch.com/optical-imaging-market.html

The increasing incidence of skin-, eye-, teeth-, and other organ-related diseases is the key driving force behind the rise of the global optical imaging market, cites the report.The report analyzes the global optical imaging market on the basis of the application and techniques of optical imaging. Ophthalmology, dermatology, dentistry, cardiology, oncology, neurology, and biotechnology and research are the main application areas of optical imaging.

The oncology segment is likely to report the fastest growth at a CAGR of 15.10% over the forecast period. Analysts expect this segment to generate US$7.4 mn revenue in the overall optical imaging market by the end of 2020.

Optical coherence tomography (OCT), near infrared spectroscopy (NIRS), hyperspectral imaging (HSI), and photoacoustic tomography (PAT) are the major techniques of optical imaging. Among these, the market for OCT dominates the global market. It occupied a share of 75.7% in 2013 and is projected to expand at a CAGR of 9.70% over the forecast period, notes the study.

Request For Custom Research: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=2093

Asia Pacific, North America, Europe, and the Rest of the World are the major regional markets for optical imaging in the global arena. According to the report, North America is leading the global optical imaging market at present and is closely followed by Europe. The high penetration rate and growing adoption of advanced optical imaging technologies have fueled the market for optical imaging significantly in this region. Analysts expect this market to maintain dominance over the forecast period.

On the other hand, the optical imaging market in Asia Pacific is likely to rise at the highest CAGR of 14.50% during the forecast period. The presence of a huge pool of patients, together with the soaring demand for innovative as well as advanced diagnostic and treatment technologies, improving healthcare infrastructure, and the rapid rise in the disposable income of consumers in this region, is the prime reason for the extensive growth of the Asia Pacific optical imaging market, says the study.

Bioptigen Inc., Carl Zeiss AG, Canon, Inc., ChemImage Corp., Headwall Photonics Inc., Heidelberg Engineering GmbH, Michelson Diagnostics Ltd., Optovue Inc., NIDEK Co. Ltd., Topcon Medical Systems Inc., and Topcon Medical Systems Inc. are the key players functioning is the global optical imaging market, states the research report.

Global Self-Care Medical Devices Market to Grow at CAGR of 7.0% from 2013 to 2019 due Increasing Prevalence of Diseases

A new research report published by Transparency Market Research states that the global self-care medical devices market has been a boon to many as it offers simple diagnostic solutions. The report, titled “Self-Care Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019”, is aimed at being a guiding document for entrepreneurs and market enthusiasts to make well-informed business decisions.

Browse the full Self-Care Medical Devices Market (Blood Pressure Monitors, Heart Rate Monitors, Body Temperature Monitors, Blood Glucose Monitors, Pregnancy/Fertility Test Kits, Pedometers, Sleep Apnea Monitors and Nebulizers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (Value and Volume),2013 - 2019 report at http://www.transparencymarketresearch.com/self-care-medical-devices.html

According to the research report, the global self-care medical devices market was valued at US$10.5 bn in 2012 and is expected to reach US$16.8 bn by 2019 at a CAGR of 7.0% between 2013 and 2019. Speedy advancements in self-care medical devices such as blood glucose monitors, blood pressure monitors, nebulizers, and heart rate meters will make a generous contribution to the growth of this market in the coming years. This market will also pace ahead due to the development and adoption of remote communication technology, which enables medical professionals to interpret the results of self-care medical devices for facilitating diagnoses and solutions.

The global self-care medical devices market is segmented on the basis of device type and geography. The devices in the global self-care medical devices market are blood glucose monitors, body temperature monitors, blood pressure monitors, nebulizers, pregnancy/fertility test kits, pedometers, sleep apnea monitors, and heart rate monitors. Geographically, this market is segmented into Europe, Asia Pacific, North America, and Rest of the World.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1752

Out of all the regions, North America held the lion’s share of about 40% in the self-care medical devices market in 2012. This region is expected to retain its leading position due to the rising prevalence of respiratory and cardiovascular diseases and other conditions resulting out of sedentary lifestyles. Furthermore, the advancements in the field of medical technologies and the growing preference for self-care devices due to the convenience they offer will propel this market in North America.

On the other hand, Asia Pacific is anticipated to grow at a rate of 9.90% from 2013 to 2019. Some of the major reasons responsible for this growth are sedentary lifestyles, rising stress levels, and a huge pool of the geriatric population, which is susceptible to conditions such as diabetes, stroke, hypertension, and cardiovascular and respiratory diseases.

Some of the important companies profiled in the self-care medical devices research report are 3M Healthcare, GE Healthcare, Abbott Laboratories, Medtronic, Inc., Philips Healthcare, and Johnson and Johnson. The research report gives an assessment of the financial overview, business strategies, marketing plans, profit maximization policies, product portfolios, and research and development activities to give a clear picture of the competitive landscape in the global self-care medical devices market.

Dental Consumables Market - Trends & Forecast up to 2018

The steady rise of the medical tourism industry, of which dental tourism is a vital part, will augur well for the growth of the global dental consumables market, states a latest report published by Transparency Market Research. The report, titled “Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018,” says that the market will exhibit a 7.1% CAGR from 2012 through 2018. The market’s valuation in 2011 was estimated to be US$14.9 bn and is projected to rise to US$23.8 bn by 2018.

Browse the full Dental Consumables Market (Dental Implants, Crowns & Bridges, Biomaterials, Orthodontics, Endodontics, Periodontics, Gloves, Floss and Brushes) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018 report at @ http://www.transparencymarketresearch.com/dental-consumables-market.html

Emerging economies such as Turkey, Hungary, and India have experienced encouraging expansion of their medical tourism markets. This has put the market for dental consumables in emerging economies in high gear. Besides promising prospects of the medical tourism industry weighing favorably in the dental consumables market, the market will also benefit from a rapidly aging population pool. This, backed by a slew of government regulations, will further impel growth, says a TMR analyst. However, the report also notes that the global dental consumables market could face restraints in the form of the lack of proper reimbursement policies and relatively low awareness about dental care in emerging nations.

The report segments the global dental consumables market on the basis of product type and geography. The key product segments are: dental implants, dental bridges and crowns, dental care essentials, orthodontics, dental biomaterials, periodontics, endodontics, and other dental consumables (such as gloves, distilled. The regional markets for dental consumables studied in the report are: North America, Europe, Asia, and Rest of the World.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=554

The largest share in the dental consumables market by product type was claimed by dental crowns and bridges segment 2011. With a share of over 25%, the segment’s strong position is credited to heightened awareness about oral hygiene. TMR analysts forecast rapid growth for the ceramic CAD/CAM market, which has been studied as a part of the larger crowns and bridges market. The report finds that the ceramic CAD/CAM market will exhibit an 18% CAGR from 2012 to 2018. The high accuracy of CAD/CAM will be its greatest driving factor, especially when it comes to diagnosing dental impairments. Cosmetic dentistry will create ample opportunities in the global orthodontics market, enabling the global orthodontics market to log the highest CAGR through the forecast period.

The report notes that in 2011, Europe held the largest share in the dental consumables market on account of oral healthcare facilities being present in high numbers in developed countries such as the U.K. and Germany. Governments here have actively funded public oral healthcare programs, creating a sizeable market for dental consumables. The Asian dental consumables market will exhibit remarkable growth thanks to the prevalence of high unmet needs in oral care and cosmetic dentistry. As the spending power of consumers in Asia continues to show a progressive rise, expenditure on oral healthcare is expected to show a simultaneous increase as well.

Providing an overview of the competitive scenario in the global dental consumables market, the report states that in 2011, Dentsply International Inc. stood as the dominant player with over 18% of the market. TMR analysts credit the company’s expansive portfolio of products for its leading position. Other companies with a notable presence in the dental consumables market are: Danaher Corporation, Nobel Biocare, 3M ESPE, Straumann, GC Corporation, Ivoclar Vivadent, and others.

Global Medical Equipment Calibration Services Market to be Propelled by Rising Demand for Innovative Medical Equipment

A research study on the global medical equipment calibration services market, published by Transparency Market Research (TMR), estimates this market to expand at a healthy CAGR of 10.10% during the period from 2014 to 2020 and reach a market value of US$2.1 bn by the end of the forecast period.The research report, titled “Medical Equipment Calibration Services Market - Global Industry Analysis, Size, Share & Forecast, 2014 - 2020”, states that the worldwide market for medical equipment calibration services stood at US$1.1 bn in 2013.

Browse the full Global Medical Equipment Calibration Services Market (By Equipment Types: Cardiovascular Monitors, Fetal Monitors, Imaging Equipment, Vital Sign Monitor, Infusion Pumps, Ventilators and Others; By Types of Services: In-House, Third Party Vendor, OEM Calibration Services) - Industry Analysis, Size, Share & Forecast, 2014 - 2020 report at http://www.transparencymarketresearch.com/medical-equipment-calibration-services-market.html

According to the report, the rising demand for innovative as well as advanced medical equipment and the increasing incidence of product recalls is projected to fuel the medical equipment calibration services market across the globe.The global medical equipment calibration services market is analyzed on the basis of the type of equipment and the type of service in this market study. Fetal monitors, vital sign monitors, imaging equipment, infusion pumps, ventilators, and cardiovascular monitors are the major types of equipment available in this market. Among these, the imaging equipment market is expected to acquire the dominant position, while the cardiovascular monitor market is likely to rise at a CAGR of 14.0% over the forecast period.

In-house calibration services, OEM calibration services, and third party calibration services are the key services provided in the worldwide medical equipment calibration services market. The in-house calibration services market is leading the global market at present. However, analysts anticipate it to report moderate growth in the coming years, owing to the increase in the penetration of third party calibration services, which are slated to post the fastest development in the overall market during the forecast period.

Considering its spread, the market study divides the global medical equipment calibration services market into the regional markets in North America, Asia Pacific, Europe, and the Rest of the World. The Europe medical equipment calibration services market stood at the leading position among all the regional markets in 2013.The presence of regional as well as international players in huge number, coupled with extensive research and development practices and strict rules enforced by governments related to medical equipment calibration, is fueling the market in Europe, says the report. Analysts at TMR expect this market to maintain its pace of growth during the forecast period.

Request For Custom Research: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=2616

North America holds the second position in the global medical equipment calibration services market at present. It generated around 33% of the overall revenue produced in the global market in 2012.Of late, Asia Pacific has been showing a tremendous rise in its market share. The regional market is projected to register the fastest growth in the overall market over the forecast period. The increased awareness among people regarding the quality of services provided in hospitals and laboratories, together with stringent government regulations, is expected to drive the Asia Pacific medical equipment calibration services market significantly during the forecast period, notes the market study.

The report also studies the competitive landscape prevalent in the worldwide market for medical equipment calibration services by analyzing the company profiles of the major players operating in this highly fragmented market.Biomed Technologies Inc., Industrial Calibration and Service Co. Inc., Fluke Biomedical, JM Test Systems Inc., Medserve Ltd., JPen Medical, NS Medical Systems, TAG Medical, STQC (Government of India), Transcat Inc., and Tektronix Inc. are some of the key participants in the global medical equipment calibration services market, states the report.

Orthopedic Trauma Fixation Devices Market - Global Forecast, Share, Size, Growth and Industry Analysis 2014 - 2020

The global orthopedic trauma fixation device market is progressing at a CAGR of 7.20% within the forecast period from 2014 to 2020. The market was valued at US$6.1 bn in 2014. By the end of 2020, the global orthopedic trauma fixation device market is expected to reach US$9.3 bn, as explained in a research report released by Transparency Market Research. The report titled “Orthopedic Trauma Fixation Devices Market - Global Forecast, Share, Size, Growth and Industry Analysis 2014 - 2020”, which is now available on the company website.

Browse the full Orthopedic Trauma Fixation Devices Market - Global Forecast, Share, Size, Growth and Industry Analysis 2014 - 2020 report at http://www.transparencymarketresearch.com/orthopedic-trauma-fixation-device-market.html

According to the report, the primary growth driver of the global orthopedic trauma fixation device market is the increasing number of fractures and spot injuries that are being treated around the world. The market also benefits from the greater expenditure rates in the healthcare industry and a practical lack of alternatives available to this market. All these factors are expected to boost the global orthopedic trauma fixation device market in the coming years.The global orthopedic trauma fixation device market is, however, impeded by factors such as the absence/inadequacy of health insurance in emerging economies, the chances of incurring a double surgery, and the high cost of operation. The report expects these restraints to act on the global orthopedic trauma fixation device market in order to withhold its maximum growth potential.

The report’s segmented analysis of the global orthopedic trauma fixation device market shows that, according to the type of fixator, the current leading segment is internal fixators. This segment is also expected to progress at a 6.80% CAGR within the report’s forecast period. Within the segment of internal fixators, the sub-segment of plate and screws is the most commonly utilized one. It is expected to progress at a 7.10% CAGR for the same forecast period.In terms of composition, the global orthopedic trauma fixation device market is currently led by bioabsorbable fixators. This segment is expected to advance at an 8.40% CAGR between 2014 and 2020, owing to the increase in the use of bioabsorbable materials by all key players in the global orthopedic trauma fixation device market.

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2155

The geographical segmentation of the global orthopedic trauma fixation device market shows North America to be the leading region for now. The fastest growing region, however, is expected to be Asia Pacific, which is advancing rapidly thanks to the developing nations of Japan, China, and India. Additionally, other nations from South East Asia along with the Eastern Mediterranean are also showing a rapid adoption rate of orthopedic trauma fixation devices.

The key players in the global orthopedic trauma fixation device market are Zimmer Holding Inc., DePuy Synthes, Stryker Corporation, Smith & Nephew, Johnson & Johnson Company, and Orthofix Holding Inc. The report states that in 2013, 47.30% of the global orthopedic trauma fixation device market was held collectively by the two largest players in the market – DePuy Synthes and Johnson & Johnson.

Global Microscopy Devices Market Outlook to 2020 Latest Industry Forecast Report Available Online by Tranparency Market Research

The global microscopy devices market is expanding at a CAGR of 7.60% within a forecast period from 2014 to 2020. The market was valued at US$5.7 bn in 2013, from which it is expected to expand to US$9.7 bn by the end of 2020, according to a research report released by Transparency Market Research. The report, titled “Microscopy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020”, is available on the company website for reference and sale.

Browse the full Microscopy Devices Market - Products (Optical Microscopes, Electron Microscopes, Scanning Probe Microscopes and Others) and Applications (Semiconductors, Life Sciences, Nanotechnology, Material Sciences and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 report at http://www.transparencymarketresearch.com/microscopy-market.html

The report includes details on all the factors that drive and restrain the global microscopy devices market. The primary driver for the growth of the market is the leap in the rate of research and development carried out in advancing the technology used today. Innovativeness in the field of microscopy devices is being highly valued and novel approaches are being considered in order to create increasingly powerful and accurate microscopes.Other factors driving the global microscopy devices market are innovations carried forward in the field of semiconductor electronics. The semiconductor industry is rapidly expanding in emerging economies, further fueling the global microscopy devices market.

The global microscopy devices market is taking long strides towards the use of nanotechnology. Global funding on the incorporation of nanotechnology in microscopy devices has increased considerably over the past few years, giving rise to a strong research and development phase for the use of nanotechnology in microscopy devices.The market is, however, restrained by the high pricing of advanced microscopes, which has hampered the global microscopy devices market’s penetration in developing nations. Additionally, the complexities related to sample preparation and instrumentation of the devices is expected to hinder the market’s overall growth rate.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=226

The report’s segmented analysis of the global microscopy devices market reveals optical microscopes to have led the products category in 2013, with a market share of 38.90%, which amounts to US$2.2 mn in global sales. The second largest product segment in 2013 was of electron microscopes.The segmentation by application reveals the global microscopy devices market leader for 2013 to have been the life sciences industry. It is expected to progress at a CAGR of 6.40% in the report’s forecast period. The second largest application segment in 2013 was the semiconductors industry. This segment is expected to expand at a 12.40% CAGR between 2014 and 2020.

The geographical analysis of the global microscopy devices market shows Asia Pacific to have dominated the market in 2013 with a share of 40.9%. The Asia Pacific microscopy devices market is expected to progress rapidly in the coming years owing to increased research and development activities conducted in schools, universities, government organizations, and research institutes.The largest investor in the global microscopy devices market’s R&D activities has been China. The key players in the global microscopy devices market are Olympus Corporation, Cameca SAS, Hitachi High-Technology Corporation, JEOL Limited, Bruker Corporation, Nikon Corporation, Danish Micro Engineering A/S, Leica Microsystems, Carl Zeiss AG, FEI Company, and NT-MDT Company.

Key segments of the Global Microscopy Devices Market

Global Microscopy Devices Market, by Product

• Optical Microscopes
  • Inverted Microscopes
  • Stereo Microscopes
  • Phase contrast Microscopes
  • Fluorescence Microscopes
  • Confocal Scanning Microscopes
  • Near Field Scanning Microscopes
• Electron Microscopes
  • Transmission Electron Microscopes (TEM)
  • Scanning Electron Microscopes (SEM)
• Scanning Probe Microscopes
  • Atomic Force Microscope (AFM)
  • Scanning Tunneling Microscopes (STM)
• Others

Global Microscope Devices Market, by Application

• Semiconductors
• Life Sciences
• Material Sciences
• Nanotechnology
• Others

Global Microscopy Devices Market, by Geography

• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Contact us:

Mr. Sudip S

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Global Surgical Navigation Systems Market Expected to Be Worth US$295.5 Million by 2020

Transparency Market Research (TMR) has recently published a research study on the global surgical navigation systems market, estimating it to expand at a CAGR of 4.50% during the period from 2014 to 2020 and reach a market value of 295.5 mn by the end of the forecast period.The research report, titled “Surgical Navigation Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020”, states that the global surgical navigation systems market stood at US$218.5 mn in 2013.

Browse the full Surgical Navigation Systems Market (Neurosurgical Navigation Systems, ENT Navigation Systems and Orthopedic Navigation Systems) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 report at http://www.transparencymarketresearch.com/surgical-navigation-systems-market.html

The rising demand for minimally invasive surgeries, together with the increasing awareness pertaining to the benefits offered by surgical navigation systems, is driving the worldwide surgical navigation systems market to a great extent. However, the high cost associated with equipment is projected to limit the sales of surgical navigation systems in the global arena, states the market report.According to the research study, the global surgical navigation systems market has been classified on the basis of product type. ENT navigation systems, orthopedic navigation systems, and neurosurgical navigation systems are the major products available in the surgical navigation systems market.

The neurosurgery navigation systems market holds the leading position in the global market. The rising frequency of complicated neurosurgeries such as surgeries of brain and spine is the key factor driving the market segment. The orthopedic navigation systems market occupies the second position in the overall market and is closely followed by the ENT navigation systems market.As per the research report, Asia Pacific, Europe, North America, and the Rest of the World are the key regional markets for surgical navigation systems across the world. Among these, the North America surgical navigation systems market has occupied the leading position. In 2013, it held a share of 40% in the overall market. The advanced healthcare infrastructure, coupled with a well-defined regulatory framework, is fueling the surgical navigation systems market in this region. Analysts expect this market to maintain its dominance throughout the forecast period.

Request For Custom Research: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=2646

The surgical navigation market in Asia Pacific is likely to register impressive growth over the forecast period, notes the market study. The growing awareness regarding surgical navigation systems is propelling the demand for these systems extensively in the region. The rising disposable income is motivating people to increase the expenditure on healthcare, which is likely to boost the Asia Pacific market surgical navigation systems market in the coming years.

The surgical navigation systems markets in Europe and the rest of the world are also expected to post a high growth rate over the forecast period, the report says.The global surgical navigation systems market is moderately concentrated and is led by a few established players including B. Braun Melsungen AG, GE Healthcare Ltd., Brainlab AG, Medtronic Inc., Stryker Corp., Siemens Healthcare Corp., and Zimmer Holdings Inc., states the research report.

The global surgical navigation systems market is segmented into:

By Products

• ENT navigation systems
• Neurosurgical navigation systems
• Orthopedic navigation systems

By Region

• North America
• Asia Pacific
• Europe
• Rest of World (RoW)

Contact us:

Mr. Sudip S

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Preventive Healthcare Technologies and Services Market - Global Industry Analysis, Trends and Forecast, 2014 - 2020

With governments across the world now perceiving preventative healthcare as a viable means to curtail the burden of healthcare costs on their respective economies, the preventative healthcare technologies and services market holds a positive outlook. Market intelligence firm Transparency Market Research states in its latest report that the global preventative healthcare technologies and services market will register a CAGR of 9.7% between 2014 and 2020, as it expands from its 2013 valuation of US$72.8 billion to US$144.8 billion. A detailed analysis of the market is conducted in the report, titled “Preventive Healthcare Technologies and Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014–2020.”

Browse the full Preventive Healthcare Technologies and Services Market (Early Detection and Screening Technologies, Prophylaxis Technologies, Advanced Technologies to Reduce Errors and Chronic Disease Management Technologies) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 report at http://www.transparencymarketresearch.com/preventive-healthcare-technologies.html

Recent reports by the World Health Organization have clearly indicated that chronic diseases are now responsible for an increasing number of deaths worldwide. In 2012, the following diseases and conditions were identified as the top three factors causing death worldwide: Ischaemic heart disease (7.4 million deaths), stroke (6.7 million deaths), and chronic obstructive pulmonary disease (3.1 million deaths). These figures turn the spotlight on preventative healthcare technologies and services. Technological advancement and improvement in prophylaxis techniques have been credited for advancing the state of preventative healthcare in recent years. This factor will thus act as the key stimulator for the global preventative healthcare technologies and services market.

The report, however, also notes that healthcare IT solutions providers are faced with an uphill task in developing economies where the high cost of such solutions will slow down the pace of market penetration. More importantly, despite milestone technological breakthroughs, if patient engagement activities are not given enough importance, both patients and healthcare providers will not adopt preventative healthcare products and technologies.

The report studies the preventative healthcare technologies and services market by segmenting it on the basis of the following criteria: Early detection and screening technologies, advanced technologies to reduce errors, flu vaccines, chronic disease management technologies, and geographical regions. Of these, early detection and screening technologies constituted the largest share of the market in 2013.

Request For Custom Research: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=822

However, through the forecast period of the report, advanced technologies to reduce errors will show the fastest pace of growth, with an estimated CAGR of 13.0% between 2014 and 2020. The report segments early detection and screening technologies into automated screening, personalized medicine, and other automated screening technologies. Personalized medicine stood as the largest market because of substantial investments in R&D related to genomics and proteomics.

On the basis of geography, the report segments the preventative healthcare technologies market into: Europe, North America, Asia Pacific, and Rest of the World (RoW). North America was not only the largest market for preventative healthcare technologies and services in 2013, but is also expected to remain the fastest through 2020. The following factors can be credited for North America’s strong position in the market: A comprehensive healthcare reimbursement scenario, a conducive regulatory environment, and the prevalence of greater awareness among patients.

An example of supportive policies is the United States Medicare Prescription Drug Improvement and Modernization Act of 2003 (PL 108-173). The act made provisions to provide physicians with grants to the tune of US$50 million to help them cover costs of acquiring, installing, or upgrading preventative healthcare and prescription software and technologies. The act also made provisions to cover the cost of training staff. This act was instrumental in encouraging healthcare facilities to adopt healthcare IT.

The report ranks Europe as the second largest market for preventative healthcare services and technologies globally. The rate of adoption of preventative healthcare will remain slow in Asia Pacific and Rest of the World (RoW). This sluggishness in growth will result from the lack of infrastructure that can support preventative healthcare technologies and services.

Cosmetic Implant Market Outlook to 2020 Latest Industry Forecast Report Available Online by Tranparency Market Research

The history of cosmetic implants can be traced back to 600 BC, when the Hindu surgeon Sushruta first performed a cosmetic surgery - a rhinoplasty using a skin graft from the cheek. The world of cosmetic surgeries has evolved massively since then, with scientists now able to design virtually perfect cosmetic implants.

Cosmetic implants surgically change your body in ways you desire. They enhance your look or reconstruct an area that may have been damaged due to an injury.The cosmetic implant market has enjoyed soaring success in the past few decades. As both surgeons and patients realize the benefits of cosmetic corrections with respect to congenital malformations such as a cleft palate or a cleft lip, the demand for cosmetic surgeries across the globe has witnessed new highs.

Both Aesthetic and Medical Reasons Contributing to the Medical Implant Market

The global cosmetic implants market is growing due to medical reasons and increasing social pressures about looks.Important contributors to the expanding cosmetic implants market,besides the obvious medical reasons, are the social pressuresof ethnic prejudice,the need to look youthful in certain careers, and coercion.Some of the other factors that lead people to opt for cosmetic implants aredepression, altering certain features (usually seen in women) for various reasons, and conditioning of the mind that veers towards unusual bodily changes.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3674

Future Outlook of Breast Implants Market is Strong

The vast world of thecosmetic implants market is divided on the basis of its several applications, types of sources, and expansive geography. Depending on the type of source, the global cosmetic implants market is divided into polymers, metals, ceramics, and biologicals. Amongst these segments, polymers accounted for the largest share in 2013. The main contributor to this success is the incredible use of polymers as a material in the production of body-contouring implants, facial implants, and breast implants. The next sub-segment to leave an impression on the global cosmetic implants market will be the metal implants segment, which will grow at a CAGR of 6.3% from 2014 to 2020. Additionally, a growing number of cosmetic dentistry practices tagged at high prices are also expected to boost the metal implants’ segment in the forecasted period.

The application segments of the global cosmetic implant market includebreast implants, facial implants, dental implants, and others such as buttocks, penile, and calf implants. Out of these segments, breast implants hold the biggest market share, with a valuation of US$945 million in 2013. Several breast implant devices such as Mentor MemoryGel, Sientra Silicone Breast Implant, and Allergen 410 Natrelle Silicone Breast Implants are fueling the growth of this segment in the past few decades. Analysts predict that the breast implant segment will be the fastest growing segment from 2014 to 2020 due to rising awareness about advantages of breast implants.

Europe to Lose Market Share to Other Emerging Regions

Geographically, the cosmetic implants market has been segmented into Europe, North America, Asia-Pacific, and Rest of the World (RoW). As of 2013, the biggest category in the global cosmetic implants market is Europe. The factors supporting this dominance were an increasing number of cosmetic dental implants, and exorbitant pricing of devices and procedures. However, in the coming five years, regions from theRoW category are expected to grow at a rate of 7% due to the reasonable cost of devices and booming medical tourism industry.

Key Enterprises in Global Cosmetic Implants Market

The global cosmetic implants market is oligopolistic in nature. About 50% of the dental implant segment is held by Nobel BioCare, Straumann AG, and DENTSPLY International. Some of the other key players in the industry include Biomet, Spectrum Medical Designs, Zimmer Holdings, Inc., 3M Health Care, GC Aesthetics, and Implantech Inc., Mentor Worldwide LLC, Sientra, and Allergan, Inc. In the coming few years, the financial outlooks of these companies, their research and development activities, and product catalogs will decide the fate of the global cosmetic implants market in the global economy

Browse Full Cosmetic Implants Market Report With Complete TOC @ http://www.transparencymarketresearch.com/cosmetic-implants-market.html

Future Trends in Cardiopulmonary Stress Testing Systems Market

A new Transparency Market Research report states that the global cardiopulmonary stress testing system market stood at US$3.3 bn in 2014 and is predicted to reach US$6.6 bn by 2023. It is expected to expand at a CAGR of 8.20% from 2015 to 2023. The title of the report is “Cardiopulmonary Stress Testing Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023”.

Browse the full Cardiopulmonary Stress Testing Systems Market (Cardiopulmonary Exercise Testing Systems, Stress ECG, Pulse Oximeters, Stress Blood Pressure Monitors, and SPECT) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 report at http://www.transparencymarketresearch.com/cardiopulmonary-stress-testing-systems.html

As per the report, the rising occurrence of coronary artery diseases such as myocardial infarction and angina pectoris will fuel the market for cardiopulmonary stress testing systems. The increasing aging population and increasing rate of obesity will further augment the market. In addition, the growth in the count of hospitals will also raise the demand for cardiopulmonary stress testing systems in the coming years. Furthermore, the rising number of new monitoring technologies has improved the rate and accuracy of diagnosis of cardiopulmonary diseases, thus boosting the overall market. On the other hand, factors including legal provisions such as the Affordable Care Act, which raises cost-cutting/containment strategies, and the sluggish growth in the count of SPECT MPI procedures may restrain the growth of the market in forthcoming years.

On the basis of product type, the market is segmented into cardiopulmonary exercise testing (CPET) systems, pulse oximeters, stress blood pressure monitors, stress ECG, and single-photon emission computed tomography (SPECT). Amongst these, cardiopulmonary exercise testing systems are further segmented into desktop CPET systems and portable CPET systems. The segment of CPET systems emerged as the largest segment of the global cardiopulmonary stress testing systems market. This is owing to the increasing occurrence of cardiac diseases, technical advancements, and the swift growth in the aging population. In addition, the rising disposable income of consumers, growing lifestyle disorders, and increasing incidence of coronary artery diseases are poised to augment the growth of the market in the forecast horizon.

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1530

On the basis of geography, the market is segmented into Europe, North America, Latin America, the Middle East and North Africa, Rest of Europe, and Rest of the World (RoW). Amongst these, North America led the global cardiopulmonary stress testing systems market in 2014 on the basis of revenue, trailed by Europe. These two regions are poised to maintain their dominance all through the forecast horizon. The reason for the dominance of these regions is the presence of a number of cardiopulmonary patients and existence of a huge number of hospitals that have been rapidly adopting cutting-edge products. On the other hand, Asia Pacific is predicted to rise at the highest CAGR in the forecast horizon. In Asia Pacific, India and China are the leading markets presenting lucrative opportunities for manufacturers of cardiopulmonary stress testing systems

According to the report, the key players operating in the market include CareFusion Corporation, COSMED, GE Healthcare, MGC Diagnostics Corporation, Nihon Kohden Corporation, Philips Healthcare, Schiller AG, Spacelabs Healthcare, SunTech Medical, Inc., and Welch Allyn, Inc.

Cardiac Pacemaker Market Dynamics and Opportunities Report by Transparency Market Research

According to a new market report published by Transparency Market Research “Cardiac Pacemaker Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023”, the cardiac pacemaker market was valued at US$6.05 bn in 2014 and is projected to expand at a CAGR of 8.7% from 2015 to 2023 to reach US$12.85 bn in 2023.

Browse the full Cardiac Pacemaker Market: (By Type: Implantable Pacemaker, and External Pacemaker ; By Technology: Dual-chamber, Single-chamber and Bi-ventricular): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 report at http://www.transparencymarketresearch.com/cardiac-pacemakers-market.html

Cardiac pacemaker is a cardiac rhythm management device that sets heart rhythm by sending electrical impulses to heart. The pacemakers support heart rate, senses native heart rate, provides physiologic heart rate and diagnostics rate. Growth in the global base of population over 65 years of age would act as a high impact driver of the market. According to the U.S. Census Board, people older than 65 years represented around 13% of the total population; this percentage is expected to grow at an estimated 20% by 2030. According to the World Health Organization, the global geriatric population is anticipated to reach 1.5 billion by 2050. Other countries aging at a rapid pace are Japan, and Germany. The impact of this driver is expected to remain high during the forecast period as the global geriatric population is constantly rising. Moreover, growing incidence of cardiovascular diseases plays a vital role in the market growth. One in 600 cardiac patients older than 65 years have sick sinus syndrome. The median age of sick sinus syndrome is 74 years. Degenerative fibrosis, amyloidosis, connective tissue diseases, and ion channel dysfunction are the common causes of SSS. A study conducted by ARIC and CHS concluded that the number of cases of SSS will increase from 78,000 in 2012 to 172,000 in 2060.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=393

Cardiac pacemakers such as implantable and external pacemakers are available in the market. Of these, implantable pacemakers held the majority share of the market in 2014, followed by external pacemaker. Implantable has been identified as the fastest growing segment during the forecast period due to product efficacy, advancement of technology, and increasing cases of bradycardia which is caused by sick sinus syndrome or atrio-ventricular block or both has led to steady rise in implantable cardiac pacemaker volume across the globe.

Based on technology, the dual-chamber pacemaker segment accounted for over 78.4% share of the global implantable cardiac pacemaker market in terms of revenue, and 71.2% in terms of volume unit sales in 2014. Moreover, the segment is expected to gain market share and emerge as the fastest growing segment during the forecast period. Biventricular pacing systems are commonly used in the treatment of refractory congestive heart failure (CHF) and ventricular dysynchrony, and is the fastest growing segment. High CAGR during the forecasted period is attributed due to high cases of ventricular dysynchrony.

North America and Europe were the largest regional markets for cardiac pacemaker in 2014, accounting for more than 87.9% share. The regions dominated the market due to steady increase in cardiac pacemaker procedural volume and rising cases of cardiac failures to bradycardia. In 2009, there were 235,567 new pacemakers implanted in the United States. Increasing number of new product approvals is another major factor that contributed to the growth of the cardiac pacemaker market in these regions. On the other hand, Asia Pacific is expected to gain market share during the forecast period and emerge as the fastest growing segment. Rapidly emerging medical tourism industry Asian countries due to low cost of surgical procedures is one of the major factors driving the cardiac pacemakers market in this region.

Medtronic, Boston Scientific Corporation, St. Jude Medical, Inc., BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Cook Medical, SORIN Group., Medico, S.p.A. are the major players operating in the global cardiac pacemakers market.

Growing Trends in Lyophilization Equipment and Services Market up to 2020

Lyophilization refers to a process used by biotech and pharmaceutical manufacturing industries to prolong life span and reduce the damage that is caused to sensitive products such as proteins, vaccines, blood plasma, antibodies, and enzymes. The key market drivers in the global lyophilization equipment and services market are increasing chances of high value pharmaceutical products getting contaminated and greater technological developments. It is of prime importance for most pharmaceutical organizations to ensure that the efficacy and function of drug molecules are duly maintained and that they are prevented from any kind of damage.

According to a recent research report, in 2013, the global lyophilization equipment and services market was estimated to be worth US$2.73 billion. By 2020, this market is expected to reach a value of US$4.80 billion, growing at a compound annual growth rate (CAGR) of 8.5% during the report’s forecast period of 2014 to 2020. Currently, the global lyophilization equipment and services market is growing robustly because of greater proliferation of manufacturing organizations all across the globe and rapid expansion of the worldwide biopharmaceutical market.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1502

Bulk Lyophilization Segment to Witness Highest Growth over the Years

The global lyophilization equipment and services market is segmented on the basis of four main parameters: type of equipment, type of service, application areas, and geography. Based on equipment type, the global lyophilization equipment and services market is categorized into freeze drying microscopes, rotary lyophilizers, tray lyophilizers, and bench-top lyophilizers.

In 2013, the largest share in the global lyophilization equipment and services market was held by the segment for tray lyophilizers with a market share that exceeded 45%. This market segment is anticipated to retain its leading position in the forthcoming years as well. On the basis of service type, this market is classified into bulk lyophilization, aseptic filling, and cycle development. Within the service segment, the highest share in the overall market for lyophilization equipment and services is held by the bulk lyophilization category.

It is anticipated that this market segment will grow at a CAGR higher than 6.5% during the forecast period. The main factors fuelling the bulk lyophilization segment are large volume drying and cost affordability. The various application areas in the global lyophilization equipment and services market are nutraceuticals, diagnostics, biopharmaceuticals, diagnostics, and pharmaceuticals. In 2013, the global lyophilization equipment and services market was dominated by the pharmaceuticals application segment.

What Will Drive the Asia Pacific Lyophilization Equipment and Services Market?

Geographically, the global lyophilization equipment and services market is classified into Europe, North America, Latin America, the Middle East, Asia Pacific, and Rest of the World. In 2013, the global lyophilization equipment and services market was led by Europe owing to factors such as greater clinical trial activities and development of newer technologies with regard to lyophilization. The Europe lyophilization equipment and services market is mainly propelled by the presence of a large pool of skilled labor. It is however anticipated that the Asia Pacific lyophilization equipment and services market will witness highest rate of growth during the forecast period owing to an expanding consumer market, suitable government policies, and widespread adoption of newer and innovative technologies. The global lyophilization equipment and services market is majorly fragmented because of greater involvement of several emerging and established biopharmaceutical firms.

The key companies operating in the global lyophilization equipment and services market are LSNE Contract Manufacturing, Irvine Pharmaceutical Services, Lyophilization Technology, Inc., W.L. Gore & Associates, Inc., GenScript, Inc., ZIRBUS Technology GmbH, Baxter BioPharma Solutions, Aseptic Technologies, Biopharma Technologies Ltd, and Alliance Healthcare Services.

Browse Full Global Lyophilization Equipment and Services Market Report With Complete TOC @ http://www.transparencymarketresearch.com/lyophilization-equipment-services.html

Autoimmune Disease Diagnostics Market Dynamics and Opportunities Report by Transparency Market Research

In 2014, the global autoimmune disease diagnostics market was estimated at US$12.3 bn and by 2023, it is projected to be worth US$17.1 bn, according to Transparency Market Research. The global autoimmune disease diagnostics market will expand at a CAGR of 3.80% during the forecast period from 2015 to 2023. Several factors will play a role in shaping the growth of the global autoimmune disease diagnostics market, the key of which are as follows:

High Prevalence of Autoimmune Diseases to Drive Global Market

The American Autoimmune Related Diseases Association (AARDA) states that around 50 million people in the U.S. are affected by autoimmune diseases. By disease type, the global autoimmune disease diagnostics market is segmented into Graves’ disease, type 1 diabetes, lupus, rheumatoid arthritis, multiple sclerosis, and Hashimoto’s thyroiditis. The rising prevalence of these autoimmune diseases around the world will drive the global autoimmune disease diagnostics market substantially.

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5351

Rising Awareness to Fuel Global Autoimmune Disease Diagnostics Market

The rising awareness around the world about autoimmune conditions will greatly benefit the global autoimmune disease diagnostics market. Furthermore, the awareness about the tests used to diagnose these conditions is also growing. By test, the global autoimmune disease diagnostics market is divided into urinalysis, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), comprehensive metabolic panel, complete blood count (CBC), autoantibody tests, antinuclear antibody tests, and others.

Expanding Health Care Expenditure to Boost Global Autoimmune Disease Diagnostics Market

The global autoimmune disease diagnostics market will also benefit from the rising healthcare expenditure in both developed and developing regions of the world. Under ObamaCare, the health care expenditure in the U.S. reached US$3.1 trillion last year, which was an increase of 5.5% as per the federal estimates. According to the WHO, the per capita healthcare spending has grown in Southeast Asia since 2001 and the growth rate was particularly high in Myanmar, the Philippines, and Indonesia. The growth was of more than 30% in most other Southeast Asian nations in the past four years.

High Equipment Cost to Challenge Global Market

Although the global autoimmune disease diagnostics market will grow by billions, it will be challenged by the high equipment cost of devices used to diagnose autoimmune diseases. Besides this, the global autoimmune disease diagnostics market will have to tackle the issue of the lack of skilled labor to handle this equipment.

Demand from Emerging Economies to Boost Global Market

By geography, the global autoimmune disease diagnostics market is segmented into Asia Pacific, Europe, North America, and Rest of the World (RoW). Players in the global autoimmune disease diagnostics market will greatly benefit from the sustained growth opportunities provided by the emerging economies of Asia Pacific.

Global Autoimmune Disease Diagnostics Market Propelled by New Product Development

The global autoimmune disease diagnostics market is witnessing a growing demand for autoimmune disease diagnostics. This has led to technical advances resulting in innovative diagnostic procedures delivering improved outcomes. Players in the global autoimmune disease diagnostics market are introducing new products, devices, and services to meet this demand.

Some of the key players operating in the global autoimmune disease diagnostics market are Abbott Laboratories, Bio-Rad Laboratories, Hoffmann-La Roche Ltd., Beckman Coulter, Inc., and Siemens Healthcare.

Browse Full Global Autoimmune Disease Diagnostics Market Report With Complete TOC @ http://www.transparencymarketresearch.com/autoimmune-disease-diagnostics-market.html

Interventional Cardiology Devices Market - Global Industry Analysis, Trends and Forecast 2014 - 2022

According to a latest study by Transparency Market Research (TMR), the global interventional cardiology devices market will firmly remain on the growth track thanks to the rising incidence of coronary artery disease, but the impact of this growth will be softened to some degree by a decrease in the average selling price of stents, a key product in the market. The report, published under the title, “Interventional Cardiology Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022," by Transparency Market Research, finds that the market’s valuation was US$8.7 bn in 2013, and will rise to US$11.2 bn by 2022, at a 2.9% CAGR through the forecast period.

Browse the full Interventional Cardiology Devices Market: (By Types: Stents, Catheters, PTCA Balloons, PTCA Guidewires, Imaging Systems and Others): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022 report at http://www.transparencymarketresearch.com/interventional-cardiology-devices.html

For the most part, the growth of the interventional cardiology devices market will result organically via regular product launches and innovative improvements to existing products”, says a senior TMR analyst.The report segments the global interventional cardiology devices market on the basis of product type and criteria. Based on product type, the market has been segmented into: percutaneous transluminal coronary angioplasty (PTCA) balloons, catheters, stents, percutaneous transluminal coronary angioplasty (PTCA) guidewires, interventional cardiology systems, and other accessories.

In 2013, the stents formed the largest product segment in the global interventional cardiology devices market, thanks to the appreciable share held by drug eluting stents in the global market. For the purpose of an in-depth analysis, the report segments stents into drug eluting stents, bare metal stents, and bio-absorbable vascular stents.

Drug eluting stents represented the largest share in the market for interventional cardiology devices worldwide in 2013. Until 2022, the drug eluting stents segment is expected to remain in the leading position in the interventional cardiology devices market by product type based on the former’s demonstrated positive patient outcomes. However, the DES segment is expected to lose market share owing to the growing popularity of bio-absorbable stents. Bioabsorbable vascular stents will report the fastest growth rate over the forecast period given their ability to prevent complications such as late-stent and in-stent restenosis.

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=853

Although this will slow down the growth rate of the DES segment, it will still continue to remain in a dominant position. Improved patient outcomes of drug eluting stents will remain the key factor fuelling their uptake.The catheters segment is sub-segmented into guiding catheters, angiography catheters, intravascular ultrasound (IVUS) catheters, and pulmonary artery catheters. The PTCA balloons segment is sub-segmented into scoring balloons, normal balloons, cutting balloons, and drug-eluting balloons. The report analyzes the largest and fastest-growing sub-segments under each of these segments.

The report covers the state of the interventional cardiology devices market in the following regional markets: North America, Asia Pacific, Europe, MENA, Latin America, and Rest of the World (RoW). In 2013, North America was the leader in the interventional cardiology devices market, with Europe taking second place. Asia Pacific stood as the third largest regional market in the same year, but is forecast to report the fastest rate of growth over the next few years.

Company profiles of leading market players form a crucial part of the report, especially for clients wanting to track the competition. For this purpose, the following companies have been profiled based on details such as product pipeline, recent M&A activity, financial status, and a SWOT analysis: St. Jude Medical, Inc., Abbott Laboratories, Inc., Terumo Medical Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Cordis Corporation, Cook Medical, Medtronic, plc, and Smiths Medical.